Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

Blood infection, medically known as sepsis, is one of the leading causes of death, because the body’s response to infection damages tissue and causes organs to fail. Africa has the ...

Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...

Researcher found that exposed individuals with confirmed TB infection -- i.e. a positive skin or blood test -- should receive priority treatment in settings with a low prevalence of the disease, ...

Treating all household contacts of someone with tuberculosis (TB) helped prevent active TB disease across age groups in the real world, but the effectiveness was highest when treating individuals who ...

Please provide your email address to receive an email when new articles are posted on . A meta-analysis revealed high risks for TB recurrence/relapse and mortality during treatment with tobacco use.

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Ocular TB is a rare eye disease due to infection from Mycobacterium tuberculosis, the same bacterium that causes tuberculosis, commonly known as TB. TB symptoms usually start in the lungs, but they ...